• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0; PRO GAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0; PRO GAV Back to Search Results
Model Number FX410T
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/05/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Manufacturing site evaluation: evaluation on-going.
 
Event Description
Country of complaint: (b)(6).It was reported that the vale is not adjustable.
 
Manufacturer Narrative
Investigation: visual inspection scratches on the outer housing of the valve were observed through the visual inspection.No significant deformations or damage were detected.Permeability test a permeability test has shown that the progav 2.0 valve is permeable.Adjustment test the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Result first, we performed a visual inspection of the progav 2.0 valve.No significant deformations or damage of the valve were detected during the visual inspection.Next, we tested the permeability, adjustability, and opening pressure of the valve, as well as the brake functionality and brake force.The progav 2.0 valve operates as expected and met all specifications.Finally, we have dismantled the valve.Inside the valve we have found a build-up of substances (likely protein).Based on our investigation, we are unable to substantiate the claim of automatic adjustment.At the time of our investigation, the progav 2.0 was able to be adjusted to all specified settings and the adjusted pressure stage was maintained.However, it is possible that the deposits observed inside the valve could have caused the malfunction in the past.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0
Type of Device
PRO GAV
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam, D-144 69
GM  D-14469
MDR Report Key7659511
MDR Text Key113271514
Report Number3004721439-2018-00121
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K141687
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFX410T
Device Catalogue NumberFX410T
Device Lot Number20025388
Distributor Facility Aware Date06/05/2018
Date Manufacturer Received07/02/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age5 YR
Patient Weight24
-
-